Early kinetics of C-reactive protein predicts oncological outcome of patients with metastatic renal cell carcinoma under first-line therapy with immune checkpoint inhibitors

被引:0
|
作者
Schuettke, V [1 ]
Kusiek, C. [1 ]
Mehralivand, S. [1 ]
Buerk, B. T. [1 ]
Thomas, C. [1 ]
Fuessel, S. [1 ]
Erdmann, K. [1 ]
机构
[1] Tech Univ Dresden, Dept Urol, Dresden, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A1031
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors
    Schuettke, Vayda
    Kusiek, Cathrin
    Fuessel, Susanne
    Thomas, Christian
    Buerk, Bjoern Thorben
    Erdmann, Kati
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (05): : 1117 - 1128
  • [2] Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors
    Vayda Schüttke
    Cathrin Kusiek
    Susanne Fuessel
    Christian Thomas
    Bjoern Thorben Buerk
    Kati Erdmann
    Clinical and Translational Oncology, 2024, 26 : 1117 - 1128
  • [3] A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma
    Jo, Hyunji
    Hong, Joohyun
    Kim, Hongsik
    Kim, Hye Ryeon
    Kwon, Ghee Young
    Kang, Kyung A.
    Park, Sung Yoon
    Kim, Chan Kyo
    Park, Byung Kwan
    Chung, Jae Hoon
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features
    Fontes-Sousa, Mario
    Calvo, Emiliano
    CANCER TREATMENT REVIEWS, 2022, 105
  • [5] Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study
    Zheng, Xinlong
    Zhang, Longfeng
    Wu, Lin
    Zhao, Jun
    Sun, Jianguo
    Fang, Yong
    Zhou, Jin
    Chu, Qian
    Shen, Yihong
    Yang, Zhenzhou
    Chen, Lijin
    Huang, Meijuan
    Lin, Xiaoyan
    Liu, Zhenhua
    Shen, Peng
    Wang, Zhijie
    Wang, Xin
    Wang, Huijuan
    Han, Zhengbo
    Liu, Anwen
    Zhang, Hongmei
    Ye, Feng
    Gao, Wen
    Wu, Fang
    Song, Zhengbo
    Chen, Shengchi
    Zhou, Chenzhi
    Wang, Qian
    Xu, Chunwei
    Huang, Dingzhi
    Zheng, Xiaobin
    Miao, Qian
    Jiang, Kan
    Xu, Yiquan
    Wu, Shiwen
    Wang, Haibo
    Zhang, Qiuyu
    Yang, Shanshan
    Li, Yujing
    Chen, Sihui
    Lin, Gen
    BMC CANCER, 2023, 23 (01)
  • [6] Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study
    Xinlong Zheng
    Longfeng Zhang
    Lin Wu
    Jun Zhao
    Jianguo Sun
    Yong Fang
    Jin Zhou
    Qian Chu
    Yihong Shen
    Zhenzhou Yang
    Lijin Chen
    Meijuan Huang
    Xiaoyan Lin
    Zhenhua Liu
    Peng Shen
    Zhijie Wang
    Xin Wang
    Huijuan Wang
    Zhengbo Han
    Anwen Liu
    Hongmei Zhang
    Feng Ye
    Wen Gao
    Fang Wu
    Zhengbo Song
    Shengchi Chen
    Chenzhi Zhou
    Qian Wang
    Chunwei Xu
    Dingzhi Huang
    Xiaobin Zheng
    Qian Miao
    Kan Jiang
    Yiquan Xu
    Shiwen Wu
    Haibo Wang
    Qiuyu Zhang
    Shanshan Yang
    Yujing Li
    Sihui Chen
    Gen Lin
    BMC Cancer, 23
  • [7] EFFECTS OF FIRST-LINE IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA NOT MEETING TRIAL ELIGIBILITY CRITERIA
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    JOURNAL OF UROLOGY, 2022, 207 (05): : E173 - E173
  • [8] Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma
    Ozaki, Kai
    Hatakeyama, Shingo
    Hamaya, Tomoko
    Okita, Kazutaka
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (04) : 362 - 364
  • [9] Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
    Saito, Kazutaka
    Tatokoro, Manabu
    Fujii, Yasuhisa
    Iimura, Yasumasa
    Koga, Fumitaka
    Kawakami, Satoru
    Kihara, Kazunori
    EUROPEAN UROLOGY, 2009, 55 (05) : 1145 - 1153
  • [10] Efficacy of first-line immune checkpoint inhibitors in patients with sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).
    Bakouny, Ziad
    Abou Alaiwi, Sarah
    Nassar, Amin
    Steinharter, John A.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Harshman, Lauren Christine
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)